DK1220667T3 - Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden - Google Patents

Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden

Info

Publication number
DK1220667T3
DK1220667T3 DK00964272T DK00964272T DK1220667T3 DK 1220667 T3 DK1220667 T3 DK 1220667T3 DK 00964272 T DK00964272 T DK 00964272T DK 00964272 T DK00964272 T DK 00964272T DK 1220667 T3 DK1220667 T3 DK 1220667T3
Authority
DK
Denmark
Prior art keywords
infertility
beta antagonists
treat endometriosis
improve fertility
fertility
Prior art date
Application number
DK00964272T
Other languages
Danish (da)
English (en)
Inventor
William J Bologna
Howard L Levine
Dominique De Ziegler
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of DK1220667T3 publication Critical patent/DK1220667T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK00964272T 1999-10-05 2000-10-04 Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden DK1220667T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (fr) 1999-10-05 2000-10-04 Traitement de l'endometriose ou de l'infertilite ou amelioration de la fertilite

Publications (1)

Publication Number Publication Date
DK1220667T3 true DK1220667T3 (da) 2004-12-06

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00964272T DK1220667T3 (da) 1999-10-05 2000-10-04 Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden

Country Status (28)

Country Link
EP (1) EP1220667B1 (fr)
JP (2) JP2003510354A (fr)
KR (1) KR100738724B1 (fr)
CN (1) CN1218694C (fr)
AR (1) AR028487A1 (fr)
AT (1) ATE271860T1 (fr)
AU (1) AU780736B2 (fr)
BR (1) BR0014548A (fr)
CA (1) CA2385974C (fr)
CO (1) CO5251423A1 (fr)
DE (1) DE60012554T2 (fr)
DK (1) DK1220667T3 (fr)
ES (1) ES2223581T3 (fr)
GE (1) GEP20043313B (fr)
HK (1) HK1044120B (fr)
HU (1) HU225990B1 (fr)
IL (2) IL148784A0 (fr)
MA (1) MA25501A1 (fr)
MX (1) MXPA02003453A (fr)
MY (1) MY129518A (fr)
NO (1) NO329663B1 (fr)
NZ (1) NZ518429A (fr)
PE (1) PE20010742A1 (fr)
PT (1) PT1220667E (fr)
TR (1) TR200200899T2 (fr)
TW (1) TWI280877B (fr)
UA (1) UA74168C2 (fr)
WO (1) WO2001024788A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (fr) 2006-06-29 2008-01-02 Polichem S.A. Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
BR112012023281A2 (pt) * 2010-03-22 2016-05-17 Repros Therapeutics Inc composto ou sal do mesmo, composição farmacêutica, métodos para produzir efeito antiprogestacional em paciente e para tratar condição dependente de progesterona e usos de composto ou sal do mesmo farmaceuticamente aceitável do mesmo e de composição
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
EP2854763B1 (fr) 2012-05-31 2018-09-26 Repros Therapeutics Inc. Formulations d'administration vaginale d'antiprogestines
JP6343619B2 (ja) 2012-11-02 2018-06-13 レプロス セラピューティクス インコーポレイティド プロゲステロン依存性病態を処置する方法およびその組成物
CN116172995A (zh) * 2023-01-17 2023-05-30 浙江大学医学院附属妇产科医院 一种沙丁胺醇在制备治疗子宫内膜异位症的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
JP2003510354A (ja) 2003-03-18
NZ518429A (en) 2004-02-27
GEP20043313B (en) 2004-03-10
HUP0203050A3 (en) 2006-02-28
HU225990B1 (en) 2008-02-28
CN1218694C (zh) 2005-09-14
AR028487A1 (es) 2003-05-14
AU780736B2 (en) 2005-04-14
WO2001024788A2 (fr) 2001-04-12
NO329663B1 (no) 2010-11-29
UA74168C2 (uk) 2005-11-15
EP1220667B1 (fr) 2004-07-28
CO5251423A1 (es) 2003-02-28
AU7525000A (en) 2001-05-10
DE60012554T2 (de) 2005-11-24
HK1044120A1 (en) 2002-10-11
NO20021591L (no) 2002-05-28
PE20010742A1 (es) 2001-07-19
CA2385974A1 (fr) 2001-04-12
HK1044120B (en) 2004-12-17
CA2385974C (fr) 2010-01-26
ATE271860T1 (de) 2004-08-15
PT1220667E (pt) 2004-11-30
MA25501A1 (fr) 2002-07-01
JP2010018639A (ja) 2010-01-28
KR20020062285A (ko) 2002-07-25
KR100738724B1 (ko) 2007-07-12
TWI280877B (en) 2007-05-11
NO20021591D0 (no) 2002-04-04
HUP0203050A2 (hu) 2003-02-28
IL148784A (en) 2006-12-31
BR0014548A (pt) 2002-06-04
MXPA02003453A (es) 2002-08-20
CN1377264A (zh) 2002-10-30
DE60012554D1 (de) 2004-09-02
MY129518A (en) 2007-04-30
IL148784A0 (en) 2002-09-12
ES2223581T3 (es) 2005-03-01
TR200200899T2 (tr) 2002-07-22
EP1220667A2 (fr) 2002-07-10
WO2001024788A3 (fr) 2001-12-06

Similar Documents

Publication Publication Date Title
NO20016350D0 (no) N-pyrazol A2A reseptoragonister
MXPA03001511A (es) Imidazol-5-il-2-amino-pirimidinas como agentes para la inhibicion de la proliferacion celular.
LU93311I2 (fr) Mancozèbe, valifenalate
DE60023167T2 (de) Pyrazol-derivate als cannabinoidrezeptor-antagonisten
IS5706A (is) Adenosín A3 viðtakastillar
EP1228535A4 (fr) Puces en face a face
BR9707391A (pt) Pirazolpirimidinas como antagonistas de receptor de crf
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
NO20022573D0 (no) N6-heterosykliske, 8-modifiserte adenosinderivater
PT1192169E (pt) C-pirazoles agonistas do receptor a2a
DE69900552D1 (de) Kristallisierendes Glasurkomponentensystem
ATE317844T1 (de) Adenosine a2a receptor antagonisten
DE60133931D1 (de) Kondensierte purinderivate als a1-adenosinrezeptorantagonisten
NO20015259L (no) Substituerte bisykliske heterosykler, fremgangsmåte for deres fremstilling og deres anvendelse som antifedme oghyperkolesterolemiske midler
DE60043571D1 (de) Thermisches Schutzrelais
DK15398A (da) Ovnanlæg, samt fremgangsmåde til fremstilling af cement
PT1165495E (pt) Derivados de resorcinol
DE59805601D1 (de) Hängebahn, insbesondere Einschienen-Elektrohängebahn
DE60036959D1 (de) Tensidzusammensetzungen, verbesserungsmittel enthaltend
NO20021591D0 (no) Behandling av endometriose eller infertilitet, eller forbedring av fertilitet
DE50011761D1 (de) Fuse für halbleiteranordnung
NO20006200D0 (no) Sikring
ATE338043T1 (de) 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten
NO20014586D0 (no) Resorcinol sammensetninger
PT1015446E (pt) Derivados de (4-piperidinil)-1h-2-benzopirano uteis como agentes antipsicoticos